UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
Amgen Korea has received an expanded indication for Blincyto, a treatment f...
by Lee Han-soo
|
2020-09-04 18:04
라인
SCM Lifescience punished for delaying adverse reaction report
The Ministry of Food and Drug Safety said it imposed an administrative warn...
by Kim Chan-hyuk
|
2020-09-04 14:54
라인
Iraq approves Hutox as 1st BTX product
Huons said that Iraqi health authorities have approved Hutox, its botulinum...
by Lee Han-soo
|
2020-09-04 14:16
라인
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
Novavax unveiled the successful results of the phase-1 clinical trial on a ...
by Kim Yun-mi
|
2020-09-03 14:50
라인
Chong Kun Dang to conduct P2 trials of Covid-19 therapy in Russia
Chong Kun Dang's anticoagulant and acute pancreatitis treatment Nafabel...
by Shim Hyun-tai
|
2020-09-03 12:36
라인
Daewoong to expand indication of Nabota in US
Daewoong Pharmaceutical said it would enter the treatment market for botuli...
by Lee Han-soo
|
2020-09-03 12:13
라인
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
The European Society of Cardiology recently announced the 2020 ESC guidelin...
by Kim Yun-mi
|
2020-09-02 16:33
라인
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
JW Pharmaceutical said Tuesday that its rheumatoid arthritis drug, Actemra ...
by Shim Hyun-tai
|
2020-09-02 14:08
라인
FDA grants priority review to Hanmi’s Oraxol
Hanmi said the U.S. Food and Drug Administration has approved the new drug ...
by Lee Han-soo
|
2020-09-02 13:06
라인
MedPacto’s oncology pipeline for blood cancer wins EU patent
MedPacto said Tuesday that it has obtained a European patent for a pharmace...
by Shim Hyun-tai
|
2020-09-01 17:14
라인
AZ requests court to nullify Dong-A ST’s avoidance of Forxiga patent
AstraZeneca filed a suit with the Patent Court to cancel the Intellectual P...
by Kim Yun-mi
|
2020-09-01 15:40
라인
MSD’s antiviral Prevymis gains insurance coverage
MSD Korea said that the Ministry of Health and Welfare has granted insuranc...
by Shim Hyun-tai
|
2020-09-01 15:05
라인
LG Chem, SK Bioscience end sales partnership with Daewoong
Two leading local pharmaceutical firms, LG Chem and SK Bioscience, have rec...
by Kim Chan-hyuk
|
2020-09-01 14:12
라인
LSK Global PS to conduct P3 trial of Sinovac's Covid-19 vaccine candidate
LSK Global Pharma Services said that it would conduct the phase 3 clinical ...
by Lee Han-soo
|
2020-09-01 12:17
라인
Doctors force drug sales reps to support ongoing strike
Physicians are asking pharmaceutical sales representatives to criticize the...
by Kim Yun-mi
|
2020-09-01 11:24
라인
MSD Korea’s Keytruda wins 2 new indications for treating cancer
MSD Korea’s immunotherapy Keytruda (ingredient: pembrolizumab) obtained two...
by Shim Hyun-tai
|
2020-08-31 16:44
라인
China gives nod to Huonland’s eye drop for allergic inflammation
Huonland, a joint venture between Huons and Beijing Northland, said Monday ...
by Shim Hyun-tai
|
2020-08-31 15:28
라인
‘Korea should introduce indication-specific drug pricing’
“Korea must introduce a system to apply different prices for a drug’s multi...
by Kim Yun-mi
|
2020-08-31 15:28
라인
Collaboration: One way to simplify complexities in drug development
The rapidly expanding global healthcare industry has created intensifying d...
by Lee Han-soo
|
2020-08-31 13:52
라인
Takeda’s Alunbrig available as primary therapy for lung cancer
The Ministry of Food and Drug Safety has approved Takeda Korea’s Alunbrig (...
by Shim Hyun-tai
|
2020-08-28 15:52
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top